{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:04:56Z","timestamp":1784250296254,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Vellore Institute of Technology, Vellore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-026-02863-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:44:50Z","timestamp":1779677090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative analysis of parametric, semiparametric and machine learning models for survival prediction"],"prefix":"10.1186","volume":"26","author":[{"given":"Salomi","family":"Arul.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2863_CR1","doi-asserted-by":"crossref","unstructured":"Bogaerts K, Komarek A, Lesaffre E. Survival analysis with interval-censored data: a practical approach with examples in R, SAS, and BUGS. Chapman and Hall\/CRC; 2017.","DOI":"10.1201\/9781315116945"},{"issue":"4","key":"2863_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/2515245918810225","volume":"1","author":"RA Klein","year":"2018","unstructured":"Klein RA, et al. Many Labs 2: investigating variation in replicability across samples and settings. Adv Methods Pract Psychol Sci. 2018;1(4):443\u201390. https:\/\/doi.org\/10.1177\/2515245918810225.","journal-title":"Adv Methods Pract Psychol Sci"},{"key":"2863_CR3","first-page":"1","volume-title":"Introducing Survival and Event History Analysis","author":"M Mills","year":"2010","unstructured":"Mills M. Introducing Survival and Event History Analysis. London: Sage; 2010. pp. 1\u2013300."},{"issue":"2","key":"2863_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc B Methodol. 1972;34(2):187\u2013202. https:\/\/doi.org\/10.1111\/j.2517-6161.1972.tb00899.","journal-title":"J R Stat Soc B Methodol"},{"key":"2863_CR5","doi-asserted-by":"crossref","unstructured":"Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. 2nd ed. Hoboken: Wiley; 2002.","DOI":"10.1002\/9781118032985"},{"key":"2863_CR6","volume-title":"Interpretable Machine Learning","author":"C Molnar","year":"2020","unstructured":"Molnar C. Interpretable Machine Learning. Morrisville: Lulu.com; 2020."},{"issue":"3","key":"2863_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1214\/08-AOAS169","volume":"2","author":"H Ishwaran","year":"2008","unstructured":"Ishwaran H, et al. Random survival forests. Ann Appl Stat. 2008;2(3):841\u201360. https:\/\/doi.org\/10.1214\/08-AOAS169.","journal-title":"Ann Appl Stat"},{"issue":"497","key":"2863_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/01621459.2011.646925","volume":"107","author":"R Zhu","year":"2012","unstructured":"Zhu R, Kosorok MR. Recursively imputed survival trees. J Am Stat Assoc. 2012;107(497):331\u201340. https:\/\/doi.org\/10.1080\/01621459.2011.646925.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"2863_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3816\/ccc.2005.n.033","volume":"5","author":"SR Alberts","year":"2005","unstructured":"Alberts SR, et al. N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil\/leucovorin with or without cetuximab after curative resection of stage III colon cancer. Clin Colorectal Cancer. 2005;5(3):211\u20133. https:\/\/doi.org\/10.3816\/ccc.2005.n.033.","journal-title":"Clin Colorectal Cancer"},{"issue":"23","key":"2863_CR10","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343\u201351. https:\/\/doi.org\/10.1056\/NEJMoa032709.","journal-title":"N Engl J Med"},{"issue":"16","key":"2863_CR11","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1200\/JCO.2006.08.2974","volume":"25","author":"JP Kuebler","year":"2007","unstructured":"Kuebler JP, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol. 2007;25(16):2198\u2013204. https:\/\/doi.org\/10.1200\/JCO.2006.08.2974.","journal-title":"J Clin Oncol"},{"issue":"13","key":"2863_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2012.385","volume":"307","author":"SR Alberts","year":"2012","unstructured":"Alberts SR, et al. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA. 2012;307(13):1383\u201393. https:\/\/doi.org\/10.1001\/jama.2012.385.","journal-title":"JAMA"},{"issue":"15","key":"2863_CR13","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.3748\/wjg.v20.i15.4208","volume":"20","author":"MJ Sotelo","year":"2014","unstructured":"Sotelo MJ, Garc\u00eda-Paredes B, Aguado C. Role of cetuximab in first-line treatment of metastatic colorectal cancer. World J Gastroenterol. 2014;20(15):4208\u201319. https:\/\/doi.org\/10.3748\/wjg.v20.i15.4208.","journal-title":"World J Gastroenterol"},{"issue":"19","key":"2863_CR14","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27(19):3109\u201316. https:\/\/doi.org\/10.1200\/JCO.2008.20.6771.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2863_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clcc.2013.12.003","volume":"13","author":"J Huang","year":"2014","unstructured":"Huang J, et al. Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147. Clin Colorectal Cancer. 2014;13(2):100\u20139. https:\/\/doi.org\/10.1016\/j.clcc.2013.12.003.","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"2863_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40291-012-0006-3","volume":"16","author":"KA Lyseng-Williamson","year":"2012","unstructured":"Lyseng-Williamson KA. Cetuximab: a guide to its use in combination with FOLFIRI in the first-line treatment of metastatic colorectal cancer in the USA. Mol Diagn Ther. 2012;16(5):317\u201322. https:\/\/doi.org\/10.1007\/s40291-012-0006-3.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"2863_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01676-9","volume":"22","author":"F Barto\u0161","year":"2022","unstructured":"Barto\u0161 F, Aust F, Haaf JM. Informed Bayesian survival analysis. BMC Med Res Methodol. 2022;22(1):238. https:\/\/doi.org\/10.1186\/s12874-022-01676-9.","journal-title":"BMC Med Res Methodol"},{"issue":"430","key":"2863_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/01621459.1995.10476563","volume":"90","author":"JM Legler","year":"1995","unstructured":"Legler JM, Lefkopoulou M, Ryan LM. Efficiency and power of tests for multiple binary outcomes. J Am Stat Assoc. 1995;90(430):680\u201393. https:\/\/doi.org\/10.1080\/01621459.1995.10476563.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"2863_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00058655","volume":"24","author":"L Breiman","year":"1996","unstructured":"Breiman L. Bagging predictors. Mach Learn. 1996;24(2):123\u201340. https:\/\/doi.org\/10.1007\/BF00058655.","journal-title":"Mach Learn"},{"key":"2863_CR20","doi-asserted-by":"publisher","unstructured":"re3data.org. Project Data Sphere. [Registry record; editing status 2024-07-24]. re3data.org; 2024. https:\/\/doi.org\/10.17616\/R31NJMJB.","DOI":"10.17616\/R31NJMJB"},{"issue":"17\u201318","key":"2863_CR21","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19990915\/30)18:17\/18<2529::AID-SIM274>3.0.CO;2-5","volume":"18","author":"E Graf","year":"1999","unstructured":"Graf E, et al. Assessment and comparison of prognostic classification schemes for survival data. Stat Med. 1999;18(17\u201318):2529\u201345. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19990915\/30)18:17\/18%3C2529::aid-sim274%3E3.0.co;2-5.","journal-title":"Stat Med"},{"issue":"1","key":"2863_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77220-w","volume":"10","author":"A Spooner","year":"2020","unstructured":"Spooner A, et al. A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction. Sci Rep. 2020;10(1):20410. https:\/\/doi.org\/10.1038\/s41598-020-77220-w.","journal-title":"Sci Rep"},{"issue":"3","key":"2863_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/JCO.2007.14.1291","volume":"26","author":"MR Weiser","year":"2008","unstructured":"Weiser MR, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26(3):380\u20135. https:\/\/doi.org\/10.1200\/JCO.2007.14.1291.","journal-title":"J Clin Oncol"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-026-02863-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-026-02863-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-026-02863-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:45:45Z","timestamp":1784249145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12874-026-02863-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1186\/s12874-026-02863-8","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"162"}}